STARTSEITE
Impressum
Datenschutz
  
 
  NEW ON THE MARKET

Second SGLT2 inhibitor for type 2 diabetes mellitus: canagliflozin (INVOKANA)

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

Withdrawal of approval: alternatives for metoclopramide drops (PASPERTIN, generics)

 
  a-t READER'S QUESTIONS AND COMMENTS
 

Are there new data on ranolazine (RANEXA) for angina pectoris?

STADA-Diagnostik-DNA-Statine-Test: Does the gene test improve treatment with statins?

 
  IN BRIEF
 

Stored neuraminidase inhibitors - an expensive "multi-system failure"

Quality review: olanzapine (ZYPREXA, generics) 10 mg tablets

Mammography: recommendation against screening programms in Switzerland

Medical apps may carry risks, but recalls are still rare

 
  SIDE EFFECTS
 

Thrombotic microangiopathy with interferon beta (e.g. REBIF)

Administration error: do not inject the rotavirus vaccine ROTARIX

 
  e a-t IN INTERNET
 

Advertising questioned: ESBERITOX COMPACT against common cold

 

© arznei-telegramm 5/2014